Sherry Korczynski - Jun 3, 2024 Form 3/A Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
SVP Sales and Marketing
Signature
/s/ Lori Braender, as Attorney-In-Fact
Stock symbol
AQST
Transactions as of
Jun 3, 2024
Transactions value $
$0
Form type
3/A
Date filed
6/12/2024, 05:14 PM
Date Of Original Report
Jun 11, 2024
Next filing
Jun 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AQST Common Stock 50K Jun 3, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares inadvertently omitted from the Form 3 filed on 06/11/2024. Shares represent Restricted Stock Units (RSUs) vesting in annual installments of 25%, 25% and 50% on the first three anniversaries of the grant date of such RSUs, subject to continued employment of the Reporting Person through each vesting date.